ArticleIn vivo (Athens, Greece)

Analysis of Onset Timing and Risk Factors for Mesalazine-related Adverse Events Using the JADER Database.

Kuninori Iwayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.